Old Web
English
Sign In
Acemap
>
authorDetail
>
Filipe Prosper
Filipe Prosper
Cancer research
Medicine
Melanoma
DUAL (cognitive architecture)
Immunomodulating Agent
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combining dual G9a/DNMTs epigenetic inhibition and immunotherapy to treat metastatic melanoma
2021
Lien De Beck
Robin Maximilian Awad
Yannick De Vlaeminck
Veronica Basso
Noelia Casares
Stefaan Verhulst
Edurne San José-Enériz
Kirsten De Ridder
Cleo Goyvaerts
Ken Maes
Karin Vanderkerken
Xabier Agirre
Filipe Prosper
Juan José Lasarte
Anna Mondino
Karine Breckpot
Show All
Source
Cite
Save
Citations (0)
Can CM272, a dual G9a/DNMT1 inhibitor, be used as an immunomodulating agent to enhance the efficacy of existing immunotherapies in melanoma?
2019
Lien De Beck
Filipe Prosper
Ken Maes
Karin Vanderkerken
Karine Breckpot
Show All
Source
Cite
Save
Citations (0)
Can CM272, a dual G9a/DNMT1 inhibitor, be used as an immunomodulating agent to enhance efficacy of existing immunotherapies in melanoma?
2018
Lien De Beck
Filipe Prosper
Karin Vanderkerken
Ken Maes
Karine Breckpot
Show All
Source
Cite
Save
Citations (0)
1